Arriving in the landscape of weight management treatment, retatrutide presents a unique strategy. Beyond many existing medications, retatrutide operates as a dual agonist, concurrently engaging both glucagon-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) receptors. The simultaneous engagement fosters various beneficial e… Read More